THE ROLE OF THE CHOLESTERYL ESTER TRANSFER PROTEIN IN LIPOPROTEIN METABOLISM

被引:33
作者
SWENSON, TL
机构
[1] Merck Sharp and Dohme Research Laboratories, Rahway, New Jersey
来源
DIABETES-METABOLISM REVIEWS | 1991年 / 7卷 / 03期
关键词
D O I
10.1002/dmr.5610070303
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:139 / 153
页数:15
相关论文
共 159 条
[1]  
The Lipid Research Clinics coronary prevention trial results. I. Reduction in incidence of coronary heart disease, J Am Med Assoc, 251, pp. 351-364, (1984)
[2]  
Geographical variation in the major risk factors of coronary heart disease in men and women aged 35–64 years, World Health Stat Q, 41, pp. 115-140, (1988)
[3]  
Levy RI, Declining mortality in coronary heart disease, Arteriosclerosis, 1, pp. 312-325, (1981)
[4]  
Miller NE, Forde OH, Thelle DS, Mjos OD, The Tromsø Heart‐Study. High‐density lipoprotein and coronary heart‐disease: a prospective case‐control study, Lancet, 1, pp. 965-968, (1977)
[5]  
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR, High density lipoprotein as a protective factor against coronary heart disease, Am J Med, 62, pp. 707-714, (1977)
[6]  
Kannel WB, Lipids, diabetes, and coronary heart disease insights from the Framingham Study, Am Heart J, 110, pp. 1100-1107, (1985)
[7]  
Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB, Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study, J Am Med Assoc, 256, pp. 2835-2838, (1986)
[8]  
Multiple risk factor intervention trial: risk factor changes and mortality results, J Am Med Assoc, 248, pp. 1465-1477, (1982)
[9]  
Kannel WB, pp. 24-29, (1986)
[10]  
Hesler CB, Swenson TL, Tall AR, Purification and characterization of a human plasma cholesteryl ester transfer protein, J Biol Chem, 262, pp. 2275-2282, (1987)